Storia in 20 fonti

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

Raccontata da

economictimes.indiatimes.com

wiwo.de+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cbsnews.comStai leggendo1 mese fa

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

originale

Timeline cronologica

martedì 21 luglio 2026·forbes.com
Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising
The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.
martedì 21 luglio 2026·biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

Confronto fonti

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

Timeline cronologica

Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses

Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Pharma heavyweights clash over anti-obesity drug ads

Novo Nordisk intente un procès à Eli Lilly pour publicité mensongère sur ses traitements anti-obésité

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Pharmaindustrie: Novo Nordisk verklagt US-Rivalen Eli Lilly

Novo Nordisk porta Eli Lilly in tribunale: pubblicità ingannevole sui farmaci anti-obesità | MilanoFinanza News

Novo Nordisk, fabricante de Ozempic y Wegovy, demanda a Eli Lilly; acusa publicidad engañosa sobre medicamentos contra obesidad y diabetes

Ozempic maker sues US rival over ad campaign

Novo Nordisk suing Eli Lilly over GLP-1 ‘outdated’ advertisements - UPI.com

Novo Nordisk demanda a Eli Lilly por “publicidad engañosa” de Zepbound frente a Ozempic y Wegovy

Novo Nordisk: Klage gegen Eli Lilly wegen unlauteren Wettbewerbs in den USA

Novo Nordisk fa causa alla rivale Eli Lilly per pubblicità ingannevole sui farmaci GLP-1

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Novo Nordisk (NYSE:NVO)